0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
'Profile' section of Vascular News and its sister publication, Interventional News
A selection of hands-on endovascular and laprascopic training opportunities for both surgeons and trainees
New technologies get an airing at this year's Charing Cross International Symposium
Superficial femoral artery trials and updates
Each year 50,000 patients are diagnosed with lesions of the thoracic aorta in Europe
Carotid trials and updates
Charing Cross is famous for its 'Great Debates'
A true pioneer of cardiovascular and vascular surgery
World class faculty of the leading endovascular and vascular specialists
The 30th Charing Cross International Symposium will take place at Imperial College, London, UK, from April 12th to 15th 2008.
Inaugural meeting of the British Society of Endovascular Therapy (BSET), Meriden, UK, held on the June 8, 2007.
11th international symposium concerning 'Critical Issues in endovascular stent grafting', took place in Groningen, The Netherlands, 2007.
Multidisciplinary European Endovascular Therapy (MEET) conference in Cannes, France.
The study will randomize patients to the GORE VIABAHN Endoprosthesis and to percutaneous transluminal angioplasty (PTA).
The technology is already being evaluated as a stand alone treatment for patients outside the three hour tPA treatment window.
Patients undergoing lower extremity atherectomy the durability was poor, with significant patency and limb loss at one-year follow-up.
Perclose closure devices are designed to close femoral artery puncture sites following diagnostic or interventional procedures.
The results were presented at the recent SVS meeting in Baltimore, MD.
Minimum level for less experienced surgeons performing endovascular aneurysm repair (EVAR) is less than ten procedures.
The purpose of the presentation was to report data from the CREST lead-in phase to determine the impact of the number of stents used in carotid artery stenting.
Plans to review its portfolio of assets and divest those considered non-strategic, and to strengthen its operating and financial performance.
"At first I was reluctant to produce medical films as I did not like to see blood!"...
DVT, other than that triggered by trauma or surgery, is now considered to be a chronic disease with a high risk of recurrence.
Editorial: Roger Greenhalgh
Dr Frank Veith, New York, presented an interesting summary of the results from the World Registry on rAAAs.
French review of literature found thoracic endovascular aortic repair (TEVAR) has a high-enough success rate and low-enough mortality.
Key questions regarding the future of carotid stenting.
This summary report comments on crucial discussion issues and records the voting of the audience on a number of questions posed, which occurred at the CX Symposium.
Vascular News talked to Muhs about his experiences in Europe, as a result of the Marco Polo Program.
"ClosureFAST provides the ability to deliver high-energy dosage to obtain a successful treatment ..."
The multi-center study is designed to evaluate the safety and efficacy of the Vascular Wrap.
Results at the Society of Interventional Radiology's 32nd Annual Scientific Meeting, in Seattle, WA, Dr Mark J Garcia.
Editorial: Ken Ouriel
0
Prepared in January 2007, the document is entitled, 'Laparoscopic repair of abdominal aortic aneurysm'.
Chaired by Martin Malina from the Vascular Centre of Malm̦ and the Seldinger Society, chaired by professor Richard Nyman.
David Kessel, at the 2007 Charing cross meeting in London.
Lars Norgren began the CX Symposium, discussing the merits and implications of TASC II.
Initial findings from a prospective, randomised, open-label, comparative study of femoropopliteal bypass with ePTFE and heparin coated ePTFE.
Dr Alberto Cremonesi, Cotignola, Italy, presented data from the CRISTALLO trial.
Dr. Konstantinos Katsanos, presented study at the recent EuroPCR meeting in Barcelona held from May 22-25 2007.
Editorial: Roger Greenhalgh
The aims of GLOBAL collaborators on Advanced Stent-graft Techniques for Aneurysm Repair (GLOBALSTAR) project.
Gary Roubin argued that experience of an operator, not speciality, is critical in the outcome of patients undergoing carotid artery stenting.
Early indications that drug elution may provide the solution for stenting in the SFA.
Dr Mike Dake presented Neinaber's results oon his behalf at the Charing Cross meeting.
Monday 16th April at the Charing Cross Symposium
Tuesday 17th April at the Charing Cross Symposium
Barry Thomas from Cook Medical's Aortic Intervention Division, presented an overview of the global market events relating to abdominal aortic aneurysm (AAA) stent grafts.
"This is an innovative stenting system that interventionalists in the US have been waiting for," said Dr Subbarao Myla, co-principal investigator of the CABERNET Trial.
The results are from the Acute Pressure Measurement to Confirm Aneurysm Sac EXclusion (APEX) trial, a prospective, non-randomized study.
According to research, durable balloon angioplasties can be done without exposure to contrast material or radiation.
Dr Juan Parodi, Miami, discussed the treatment of abdominal aortic aneurysms (AAA) and hypothesised its future.
A fascinating exchange of views at this year's VEITHsymposium, three experts on venous disease presented data on various treatments for varicose veins.
Results from the European first-in-man study of the Vascular Wrap paclitaxel-eluting (Angiotech Pharmaceuticals) device.
...and in addition to stent grafts, new advances in laparoscopic surgery and graft infection were highlighted.
The Prot©g© RX Carotid Stent has an innovative delivery system that allows physicians to place the stent accurately and also provides great visible confirmation due to its distinct radiopaque markers.
The results were eagerly awaited as there are relatively few studies analysing long-term safety and effectiveness of endovascular treatment.
The GORE PROPATEN Vascular Graft is specifically designed for those vascular procedures in which the risk of acute graft thrombotic failure is of clinical concern.
The introduction of the Act comes the UK government is expected to endorse a similar screening program, supported by the Vascular Society of Great Britain and Ireland.
Katzen praised Wholey's 'great' achievements in the field of endovascular therapy and described him as a 'distinguished part of the ISET family
No let up in the carotid stenting vs. surgery debate at the VEITHsymposium as Sir Peter Bell, Leicester, UK, and Jay Yadav came head to head.
Professor Roger Greenhalgh pays a fitting tribute to Professor Edmondo Malan at this year's IVEC 2006 meeting.
Stephen Greenhalgh, London, UK, presented data in November 2006 at the Carpe Diem Vascular meeting in Barcelona, Spain.
Z-Trak Plus Introduction System provides trackability and manoeuvrability for precise, controllable device orientation and deployment of the company's thoracic aneurysm stent graft
"...This monitor will be easy for my patients to use at home, and is expected to give early warning of the need for treatment, avoiding hospitalisation and deterioration in the patient's condition."
"The Valiant stent graft has quickly become the most widely used thoracic graft outside the United States..."
The results from three studies revealed that stenting is a safe and effective treatment option for treating SFA lesions
Presentation of results from 2 studies at this years annual meeting of the Vascular Society.
The event was again organised by Peter Taylor and John Reidy of Guy's and St Thomas' NHS Foundation Trust, London, UK.
...The clinical data for the Powerlink System is compelling. Endologix has set the bar
The new system combines real-time imaging with the company's FDA-cleared SilverHawk Plaque Excision system.
At what aneurysm size does the risk of an endovascular procedure become less than the risk of observing the patient without definitive treatment?
The results were presented at the CRF eighteenth annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium
NICE..."current evidence suggests that stent placement for carotid artery stenosis is safe and efficacious in the short-term
A team led by Dr Donald Elbert, have synthesised new materials to protect against blood clotting
New UK subsidiary will begin sales of VNUS Closure products directly in the UK market 2007
The CHARISMA trial designed to investigate whether clopidogrel could be applied to broad population of high-risk patients receiving low-dose aspirin therapy
The conference featured talks and demonstrations from the experts in the field from UK, Europe and USA
Dr Rao Vallabhaneni, consultant vascular and endovascular surgeon, Royal Liverpool University Hospital, UK, examines...
Italian Registry of Vascular Surgery (SICVEREG). The Registry now contains data from 85 centres
At this year's meeting were many challenging questions including - what evidence is there for endovascular treatment'?
Comments by Professor Johannes Lammer
Dr Marc Bosiers discusses whether device characteristics affect outcomes in carotid artery stenting
Interest generated in the use of angioblasts for neovascularization of ischemic or injured tissue
ESVS meeting, delegates were honoured to have a distinguished panel before them.
Largest merger in medical device industry history takes a turn
Dramatic implications for the future of stenting in the superfemoral artery (SFA).
Training programme that aims to enhance the cooperation between both disciplines and achieve a closer working relationship
Presentation of the results from EVA-3S and the SPACE trials
Vascular News talks to Jesper Swedenborg
The study was designed to examine the safety and efficacy of the Relay thoracic stent-graft
First patient has been enrolled in the CELLO (CliRpath Excimer Laser System to Enlarge Lumen Openings) trial
Endovascular 'bail-out' option to treat proximal endograft fixation failure
After treatment with plaque excision, 100 patients will be followed for a year using duplex ultrasound
The PROOF study will be designed with amputation-free survival as the primary endpoint
..."The GORE Neuro Protection System is an important advancement in protecting patients during carotid artery stenting procedures"
Clinic statement confirmed that Yadav lost his position as part of larger refining conflict of interest processes.
Clinical studies have shown this direct mechanism of action provides rapid clot dissolution with a well-tolerated safety profile
Study plans to enrol up to 50 patients with chronic deep venous insufficiency and venous ulcers (present for at least six months)
Training sessions are excellent opportunity to get acquainted with the newest of techniques and products available on the endovascular market
Dr John Jones states, patients with a Type 2 endoleak for more than six months after EVAR, should be considered for early reintervention
Endovascular procedures available to nearby population in Northern Greece, south of the independent Macedonia of the former Yugoslavia
Ten-centre, randomised trial seeks to determine that haemodialysis patients experience fewer graft failures than those patients receiving the Lifespan graft alone
Venous Registry is to produce an annual publication similar to the vascular and adult cardiac surgical reports
The EPIC (Evaluating the Use of the FiberNet Embolic Protection Device In Carotid Artery Stenting) study
Study investigates mortality and the re-intervention rate due to dissection related disease
TASC 2006 recommendations reflect the latest developments in technology and techniques in the endovascular approach to lesions of the superficial femoral artery (SFA)
EUROSTAR Report On Belgian Endovascular Abdominal Aortic Aneurysm Elective Repair Between 2001 And 2005 - EUROSTAR Report On The RIZIV Convention
Vascular News speaks to Rodney White
The great varicose vein debate
Session chaired by Jim Reekers
CX Vascular Revision Course
Gore's Satellite Symposium
Clot Lysis and Thrombolytic Therapy
Imperial Innovations
Greatest Great Debate?
Vascular Surgery and Interventional Radiology
Ross Milner's experience with CardioMEMS
Takao Ohki's first-in-man experience with the Aptus endostapler device
Gore Aortic Summit
Medtronic Vascular Talent Thoracic Stent Graft System
Juan Parodi speaking at the International Congress
Mark H Wholey speaks at ISES
American Registry for Diagnostic Medical Sonography
FoxHollow Technologies' SilverHawk plaque excision system
The question of cerebral protection
Femoral Artery Stenting Trial
Results from two trials
New entity is the world's third largest medical device company
AHRQ Review
Roger Greenhalgh launches a robust defence of the UK EVAR trials
In an effort to improve its profile
Giving financial, structural and entrepreneurial advice to small, independent and emerging companies
From 29th June to July 1st
Entertaining and provocative session
at Charing Cross
With the support of Medi
Making its debut at this year's Charing Cross
Returning at this year's Symposium
A highlight of the 2006 CX Symposium
New techniques, technologies and horizons
Past-president of the European Society for Vascular Surgery
Recommendations compared
World class faculty of the leading endovascular and vascular specialists
Vascular News talks to Tom Fogarty
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Vascular News talks to Professor Piergiorgio Cao
Robotic laparoscopic aortic surgery could become a mainstream procedure within years
Criticism from trade union Unison
Annual meeting of the Vascular Society
highlight on stroke in the UK
The battle between Johnson & Johnson and Boston Scientific
Long-awaited results published
Torino-Molinette, Italy
Results presented recently in Washington
Increase in peripheral interventional procedures performed by interventional cardiologists
Vascular News - North America talks to Dr Enrico Ascher
Vascular News talks to Fabrizio Benedetti-Valentini
Following on from the success for the XIX Annual Meeting
Dr William A Gray at the TCT meeting
Dangers of leaving the decision in primary care
JP Morgan has reported there was mixed news for the company at the recent meeting
4th National Congress of the Italian Society of Vascular and Endovascular Surgery
Meeting in Helsinki
Guest speakers concluded that the Registry had provided the vascular community with many valuable lessons
Vascular surgeons, cardiologists and radiologists traditional work area separation to change
Hospital Centro M©dico de Caracas in Caracas, Venezuela
Results from a study comparing the outcomes of stenting vs PTA
CAS is fast becoming the treatment of choice
Are single center results for emergency EVAR comparable?
Largest in the healthcare industry
New randomised controlled trial with two prongs
Vascular News talks to Christos D Liapis
Conference organiser announcement
Dr Enrico Ascher discusses
Despite facing various challenges
Session entitled, "Should small aneurysms be treated with endografts?"
The only online European registry on carotid endovascular procedures
Dr Yves Alimi presented his experience in minimally invasive video-assisted aortic surgery
Held in Barcelona, Spain
The latest issues surrounding endovascular aortic repair and carotid stenting
Vascular News attended the recent Masterclass V
Major Charles J Fox discusses use of arteriography
Paper presented by Dr Nick Cheshire
At the SVS meeting
limitations of filter-type cerebral protection devices
136 patients with type B aortic dissections
The role of hybrid procedures for acute type A dissection
Vascular News highlights the latest research developments for the treatment of varicose veins
EVAR and DREAM trials essentially the same
Once again the DREAM trial message conflicts
Vascular News talks to Dr Kenneth Ouriel
Vascular News talks to Juan Parodi
Presentations made at the American Venous Forum
Overview of the keynote on the origins of innovations by Thomas J. Fogarty
At the International Congress XVIII on Endovascular Interventions in Phoenix, Arizona
Including SIROCCO II, ASTRAL, MAVEric, SAPPHIRE and MIMIC
Over 1,500 people from 60 countries attended the 27th Charing Cross International Symposium
The Preliminary 30-day results from the Phase I CREATE trial
Vascular community presents a united front urging the CMS to reconsider its approach to carotid artery stenting
At the moment the market for Thoracic grafts appears ready to expand significantly in the US
Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST) study expansion
Vascular News reports of two company-sponsored trials
The results from the New ERA Study
Results presented by Dr Martin Schillinger
Presented at Charing Cross by Dr Ron Fairman
Optimal treatment strategy for patients with asymptomatic carotid disease
Positive preliminary safety results have been revealed.
Last year's Charing Cross International Symposium reached new heights
This year sees the return of the Innovation Showcase, providing an opportunity for leading clinicians and industry professionals to interact over the development of new technologies in the vascular and endovascular device field.
Some of Europe's and North America's leading vascular specialists and interventionalists have shared their views with Vascular News and its sister paper, Interventional News, over the last 12 months
Charing Cross International Symposium continues to offer its training day in partnership with the European Association of Vascular Surgeons in Training
Making its debut at this year's CX Symposium is the Training Village, which will be held in the Seminar and Learning Centre, 5th floor of the Sherfield Building, Imperial College
With the support of Philips Ultrasound
This year's CX Symposium will see the introduction of Medtronic's innovative thoracic endograft device, the Valiant Thoracic Stent Graft with Xcelerant Delivery System.
Gore's Medical Products Division will be celebrating their 30th anniversary at this year's Charing Cross Symposium
Once again the Charing Cross Symposium tries something different. The aim this year is to come to a consensus, lesion by lesion
11th Annual Meeting
Vascular News talks to Ted Diethrich
Vascular News spoke to Tom O'Donnell
Carotid stenting is clearly the hot topic at the moment
Controversies over the value of carotid stenting in patients at high risk for carotid endarterectomy
Johnson & Johnson announced an agreement to buy Guidant
The editors of Vascular News debated this at the recent VEITHsymposium
The ESCHAR study results show that superficial venous surgery reduces venous ulcer recurrence.
Comparing the long term results of endovenous laser and endovenous RFA Therapy
12-month results of the BEST-BTK study
Screen Abdominal Aortic Aneurysms Very Efficiently
The FDA approval of the first carotid artery stenting system in the US took place on August 31, 2004.
By Roger Greenhalgh, Sydney 11th December 2004
Frank Veith talks to Vascular News
Peter Harris talks to Vascular News
Dr David Rosenthal, Surgery Program Director at Atlanta Medical Center, talks to Vascular News
Peter Harris explained how having successfully completed its initial audit cycle Eurostar is taking on new functions
Dr Tom Fogarty presented with 4th annual achievement award
The Vascular Interventional Advances (VIVA) 2004 meeting, a national educational meeting on peripheral vascular interventions, was held in Las Vegas in October
Results of the non-industry sponsored DIABETES trial were presented at TCT 2004 by Dr Manuel Sabat̬ of the Hospital Clinico San Carlos in Madrid, Spain
The attractive setting of San Domenico Palace in Taormina hosted the fourth Sicilian Vascular Symposium between October 21 and 23.
From September 26-29 the northern town of Turin hosted the 3rd national congress of SICVE (the Italian Society of Vascular and Endovascular Surgery)
Vascular News attended the International Course for Endovascular Procedures (ICEP) 2004, held in Rome from October 18 to 20.
This year's Eurostar contributors' meeting focused on post-operative surveillance after endovascular aneurysm repair.
Vascular surgeons have split over the SVS initiative
Cook restructures its license agreement with Angiotech
0
CMS has issued a final National Coverage Determination
During TCT, Phase II trial results showed the potential of alfimeprase to treat acute peripheral arterial occlusion (PAO), also known as "leg attack".
The BVF will continue to operate much as it has done before but under the auspices of the Vascular Society.
Before thinking about DES in the SFA, changes in the mechanical performance of nitinol are mandatory
Vascular surgery has come of age in Europe
Conclusions drawn by the two groups of investigators differed dramatically
14th Congress of the Mediterranean League of Angiology and Vascular Surgery
Young Russian vascular surgeon - Alexei Svetlikov
The most important European meeting of the year for aortic endografting
37th Annual Meeting of the Vascular Surgical Society of Great Britain and Ireland
Delivering the best medical therapy to the peripheral vascular disease patient
300 people attend the Birmingjam Vascular and Endovascular Masterclass 2003
ISES pays tribute to the founders of the society
ISES General Assembly holds debate on SAPPHIRE
Cryoplasty a hot topic at ISET
ISET meeting suggests that cutting balloons may be coming of age
Study on endovenous laser therapy treatment for varicose veins
What happens when the drug is gone?
ISET celebrates 15 years of innovation in education
US aneurysm repair trial gets under way
Long-term results of the SIROCCO trial announced at ISET
Philippe Piquet talked to Vascular News about his work at the H̫spital Sainte-Marguerite, part of l'Assistance Publique-H̫pitaux de Marseille in France.
Eric Verhoeven talked to Vascular News about a Dutch hospital initiative for the treatment of AAAs
Wilhelm Sandmann has poured cold water on endovascular aneurysm repair, claiming that it is overdone with widespread usage remaining unjustifiable.
Drug-eluting stents were a hot topic at EuroPCR with the presentation of results from the first 400 patients enrolled in the SIRIUS trial.
Coronary vascular stenting is expected to go through a massive change over the next few years with drug-eluting stents replacing bare-wire stents and non drug-coated stents.
The European Society for Vascular Surgery recently balloted its members by way of a questionnaire on their website. Over 200 responses were received and the results were generally an affirmation of what the society is doing for its members.
Nine-year results of UK Small Aneurysm Trial were presented at the 24th Charing Cross International Symposium.
The British Vascular Foundation and the London Vascular Debating Group held a joint meeting
Cardiostim focuses on Endostim
Held in June 2002
Held in June 2002
The results of the ESVS ballot
Guidant has agreed to acquire Cook
13-15 April 2003
Vascular News interviewed Mauro Ferrari
Yves Alimi spoke to Vascular News after the Carpe Diem Angiologica meeting in Barcelona
A report from the Austrian Vascular Society Meeting
UEMS EBVS activities
Vascular registries collaborators' group meeting
A debate on the possible impact of the 48-hour EU directive
Eurostar collaborators' meeting at the ESVS
Report on the ESVS annual meeting in Turkey
SAPPHIRE and ACSRS results
